Smoking Cessation among Patients with Coronary Heart disease.

Effectiveness of two intensive counselling methods for smoking cessation and relapse prevention in persons with coronary heart disease.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON20676

Enrollment

894

Registered

2009-12-15

Start date

2009-10-15

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

'coronary heart disease' and 'smoking cessation' 'coronaire hartziekte' en 'stoppen met roken'

Interventions

The interventions consist of intensive counselling by smoking cessation professionals, either by telephone in one intervention and by face-to-face counselling in the other. These comparable interventi

Eligibility

Inclusion criteria

Inclusion criteria: Patients who are admitted with coronary heart disease at cardiac wards and smoked at least five cigarettes a week prior to hospital admission will be recruted. Inclusion criteria are: 1. Stable cardiac situation; 2. One of the following diagnoses: angina pectoris, myocardial infarction, post-PCI, post-CABG or a combination; 3. 18 years or older; 4. Sufficiently fluent in Dutch and able to read Dutch.

Exclusion criteria

Exclusion criteria: Exlusion criteria are: 1. Unstable cardiac situation; 2. Terminal stage of the disease; 3. Smoking less than 5 cigarettes per week; 4. Smoking cessation more than one month prior to hospital admission; 5. Insufficiently fluent in Dutch.

Design outcomes

Primary

Measure	Time frame
Primary outcome will be point prevalence abstinence from smoking (PPA) after 6 and 12 months. PPA is considered to be the most sensitive and valid measure of smoking cessation.	—

Secondary

Measure	Time frame
Secondary outcomes will be continued abstinence, quit attempts, lapses and relapse into smoking. Health outcomes that will be measured are new coronary events, hospital readmissions for coronary events, TC/HDL cholesterol ratio, blood pressure, prescribed medication, number of visits to the cardiologist since discharge. In telephone interview after 6 and 12 months will assess: visits to general practitioner in past months, cardiology outpatient visits in past months, hospitalisations in past months and death related to cardiovascular disease, contacts with caregivers, absence from work due to illness, and resource use specifically for the interventions. Patients who die during the study will directly be excluded from the study to avoid any further contact with family. OTHER MEASUREMENTS: The baseline measurement (questionnaire) and the 6 and 12 months post-test (telephone interview) will also include factors that are related to smoking cessation and/ or relapse among this patient population. These include: 1. Demographics; 2. Smoking related factors (smoking history, addiction); 3. Disease related factors (severity of disease, diagnosis); 4. BMI; 5. Psychological state (depression, anxiety, type D behaviour); 6. Smoking cessation related cognitions (for example attitude, selfefficacy, smoking behaviour of important others) only measured baseline.	—

Measure

Time frame

Secondary outcomes will be continued abstinence, quit attempts, lapses and relapse into smoking. Health outcomes that will be measured are new coronary events, hospital readmissions for coronary events, TC/HDL cholesterol ratio, blood pressure, prescribed medication, number of visits to the cardiologist since discharge. In telephone interview after 6 and 12 months will assess: visits to general practitioner in past months, cardiology outpatient visits in past months, hospitalisations in past months and death related to cardiovascular disease, contacts with caregivers, absence from work due to illness, and resource use specifically for the interventions. Patients who die during the study will directly be excluded from the study to avoid any further contact with family. OTHER MEASUREMENTS: The baseline measurement (questionnaire) and the 6 and 12 months post-test (telephone interview) will also include factors that are related to smoking cessation and/ or relapse among this patient population. These include: 1. Demographics; 2. Smoking related factors (smoking history, addiction); 3. Disease related factors (severity of disease, diagnosis); 4. BMI; 5. Psychological state (depression, anxiety, type D behaviour); 6. Smoking cessation related cognitions (for example attitude, selfefficacy, smoking behaviour of important others) only measured baseline.

—

Contacts

Public ContactNadine Berndt

Postbus 2960

nadine.berndt@ou.nl+31 (0)45 576 2172

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)